U.S. Post-Menopausal Dyspareunia Market By Therapy Type (Local Vaginal Estrogen, Non-Estrogen Prescription, GSM-Specific OTC); By Route of Administration (Vaginal, Oral); By Patient Type (Estrogen-Eligible, Estrogen-Averse / Contraindicated); By Care Setting (OB-GYN, Primary Care, Retail / OTC); By Region (North America); Segment Revenue Estimation, Forecast, 2025–2035

1. Introduction and Strategic Context

The U.S. Post-Menopausal Dyspareunia Market — anchored within the broader Genitourinary Syndrome of Menopause (GSM) space — is projected to grow from USD 180 million in 2025 to approxima... Read More

Microbiome-Based Therapies For Vaginal & Reproductive Health Market By Indication (Recurrent Bacterial Vaginosis, Pregnancy-Associated Dysbiosis, Infertility-Linked Dysbiosis, Postmenopausal Vaginal Dysbiosis); By Therapeutic Modality (Live Biotherapeutic Products [Single-Strain, Multi-Strain], Vaginal Microbiota Transplants, Other Experimental Modalities); By Route of Administration (Vaginal, Oral, Hybrid); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Microbiome-Based Therapies For Vaginal & Reproductive Health Market is forecast to expand steadily at a CAGR of 6.8%, reaching approximately USD 1.04 billion in 2030, ... Read More

Serological Pipettes Market By Material (Plastic, Glass); By Volume Range (1 mL, 2 mL, 5 mL, 10 mL, 25 mL, 50 mL); By End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Hospitals & Clinical Labs, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Serological Pipettes Market is projected to grow steadily, reaching an estimated value of USD 548.7 million by 2030, up from USD 358.2 million in 2024, at a CAGR o... Read More